First Time Loading...

Uniqure NV
NASDAQ:QURE

Watchlist Manager
Uniqure NV Logo
Uniqure NV
NASDAQ:QURE
Watchlist
Price: 4.69 USD 0.21% Market Closed
Updated: May 5, 2024
Section:
 

Wall Street
Price Targets

QURE Price Targets Summary
Uniqure NV

Wall Street analysts forecast QURE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for QURE is 21.26 USD with a low forecast of 7.07 USD and a high forecast of 31.5 USD.

QURE Lowest Forecast
Wall Street Target
7.07 USD
51% Upside
QURE Average Forecast
Wall Street Target
21.26 USD
353% Upside
QURE Highest Forecast
Wall Street Target
31.5 USD
572% Upside
Lowest
Price Target
7.07 USD
51% Upside
Average
Price Target
21.26 USD
353% Upside
Highest
Price Target
31.5 USD
572% Upside
Uniqure NV Competitors:
Price Targets
Z
ZURA
Zura Bio Ltd
262% Upside
B
2315
Biocytogen Pharmaceuticals Beijing Co Ltd
106% Upside
B
002038
Beijing SL Pharmaceutical Co Ltd
396% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
33% Upside
Z
ZURA
Zura Bio Ltd
262% Upside
B
2315
Biocytogen Pharmaceuticals Beijing Co Ltd
106% Upside
B
002038
Beijing SL Pharmaceutical Co Ltd
396% Upside
688687
Beijing Kawin Technology Share-holding Co Ltd
33% Upside
BNTX
BioNTech SE
30% Upside
A
AELIS
Aelis Farma SA
62% Upside
M
MAB
Mabion SA
3% Downside
S
688373
Shanghai MicuRx Pharmaceutical Co Ltd
71% Upside

Revenue
Forecast

Revenue Estimate
Uniqure NV

For the last 8 years the compound annual growth rate for Uniqure NV's revenue is 5%. The projected CAGR for the next 3 years is 98%.

5%
Past Growth
98%
Estimated Growth
Estimates Accuracy
8%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Uniqure NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Uniqure NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
What are analyst estimates?

See Also

Summary
QURE intrinsic value, competitors valuation, and company profile.
DCF Valuation
QURE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
QURE stock valuation using valuation multiples.
Wall Street Estimates
QURE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
QURE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is QURE's stock price target?
Price Target
21.26 USD

According to Wall Street analysts, the average 1-year price target for QURE is 21.26 USD with a low forecast of 7.07 USD and a high forecast of 31.5 USD.

What is Uniqure NV's Revenue forecast?
Projected CAGR
98%

For the last 8 years the compound annual growth rate for Uniqure NV's revenue is 5%. The projected CAGR for the next 3 years is 98%.

ALPHA SPREAD
Join more than 134,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.